Pharming Group saw the highest growth of 1.99% in patent filings and 1.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Pharming Group’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Pharming Group has been focused on protecting inventions in European Patent Office(EPO) with three publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 67% filings and 33% grants. The European Patent Office(EPO), Denmark(DK), Finland(FI), and Portugal(PT) patent Office are among the top ten patent offices where Pharming Group is filings its patents. Among the top granted patent authorities, Pharming Group has 33% of its grants in European Patent Office(EPO), 33% in Finland(FI) and 33% in Portugal(PT).
Sanofi could be the strongest competitor for Pharming Group
In terms of grant share, Pharming Group stands in fifth position among its competitors. Sanofi and Pharming Group secured the top positions according to recent patent publication data.
Patents related to rare diseases and Covid-19 lead Pharming Group's portfolio
Pharming Group has the highest number of patents in rare diseases followed by, Covid-19. For rare diseases, nearly 50% of patents were filed and no patents were granted in Q2 2024.
Severe acute respiratory syndrome (sars) related patents lead Pharming Group portfolio followed by acute respiratory distress syndrome, and viral infections
Pharming Group has highest number of patents in severe acute respiratory syndrome (sars) followed by acute respiratory distress syndrome, viral infections. For severe acute respiratory syndrome (sars), nearly 40% of patents were filed and 33% of patents were granted in Q2 2024.
For comprehensive analysis of Pharming Group's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
